Your browser doesn't support javascript.
loading
Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1.
Spans, Lien; Van den Broeck, Thomas; Smeets, Elien; Prekovic, Stefan; Thienpont, Bernard; Lambrechts, Diether; Karnes, R Jeffrey; Erho, Nicholas; Alshalalfa, Mohammed; Davicioni, Elai; Helsen, Christine; Gevaert, Thomas; Tosco, Lorenzo; Haustermans, Karin; Lerut, Evelyne; Joniau, Steven; Claessens, Frank.
  • Spans L; Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, University of Leuven, Campus Gasthuisberg, Leuven, Belgium.
  • Van den Broeck T; Current address: Laboratory for Genetics of Malignant Disorders, Department of Human Genetics, University of Leuven, Campus Gasthuisberg, Leuven, Belgium.
  • Smeets E; Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, University of Leuven, Campus Gasthuisberg, Leuven, Belgium.
  • Prekovic S; Department of Urology, University Hospitals Leuven, Campus Gasthuisberg, Leuven, Belgium.
  • Thienpont B; Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, University of Leuven, Campus Gasthuisberg, Leuven, Belgium.
  • Lambrechts D; Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, University of Leuven, Campus Gasthuisberg, Leuven, Belgium.
  • Karnes RJ; Vesalius Research Center, VIB, Leuven, Belgium.
  • Erho N; Laboratory of Translational Genetics, Department of Oncology, University of Leuven, Campus Gasthuisberg, Leuven, Belgium.
  • Alshalalfa M; Vesalius Research Center, VIB, Leuven, Belgium.
  • Davicioni E; Laboratory of Translational Genetics, Department of Oncology, University of Leuven, Campus Gasthuisberg, Leuven, Belgium.
  • Helsen C; Department of Urology, Mayo Clinic, Rochester, MN, USA.
  • Gevaert T; Research and Development, GenomeDx Biosciences, Inc., Vancouver, BC, Canada.
  • Tosco L; Research and Development, GenomeDx Biosciences, Inc., Vancouver, BC, Canada.
  • Haustermans K; Research and Development, GenomeDx Biosciences, Inc., Vancouver, BC, Canada.
  • Lerut E; Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, University of Leuven, Campus Gasthuisberg, Leuven, Belgium.
  • Joniau S; Organ Systems, Department of Development and Regeneration, University of Leuven, Campus Gasthuisberg, Leuven, Belgium.
  • Claessens F; Department of Urology, University Hospitals Leuven, Campus Gasthuisberg, Leuven, Belgium.
Oncotarget ; 7(17): 24326-38, 2016 Apr 26.
Article en En | MEDLINE | ID: mdl-27014907
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteínas Proto-Oncogénicas / Metilación de ADN / Genómica / Epigenómica / Oxigenasas de Función Mixta Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteínas Proto-Oncogénicas / Metilación de ADN / Genómica / Epigenómica / Oxigenasas de Función Mixta Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Año: 2016 Tipo del documento: Article